Amit Akirov, MD, Author at Pulmonology Advisor

Increased Risk for CVST With Thrombocytopenia in J&J COVID-19 Vaccine Recipients

By

Amit Akirov, MD

June 14, 2021

This case series described the different reports of CVST with thrombocytopenia following receipt of the Johnson & Johnson COVID-19 vaccine.

elderly man receiving COVID-19 vaccine wearing a mask

General Pulmonology

Safety and Efficacy of SARS-CoV-2 mRNA Vaccines in Patients With Chronic Inflammatory Diseases Demonstrated

By

Amit Akirov, MD

May 4, 2021

The immunogenicity and safety of SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions receiving immunosuppressive therapy were determined.

COPD Advisor Channel

Targeting Chronic Obstructive Pulmonary Disease Endotypes

By

Amit Akirov, MD

February 16, 2021

This review of current literature discusses emerging therapies directed at COPD endotypes and pathobiological processes that manifest as the disease.

COPD Advisor Channel

The Need for New Biological Targets for Therapeutic Intervention in COPD

By

Amit Akirov, MD

January 28, 2021

Chronic obstructive pulmonary disease (COPD) continues to be a major cause of disability and is one of the leading causes of mortality worldwide. Here, we summarize COPD pathology, available treatment options and additional potential pathways and targets for new therapeutic development.

Lung Infection

Neuropathological Changes in Autopsied Brain Tissue of Patients With COVID-19

By

Amit Akirov, MD

November 20, 2020

Neuropathological changes in patients with coronavirus disease 2019 are relatively mild, with neuroinflammatory changes in the brain stem most often found.

Asthma

Asthma Is Associated With Increased Risk for Osteoporosis

By

Amit Akirov, MD

October 8, 2020

Researchers analyzed the association of asthma and its subgroups with osteoporosis in the Korean adult population, and determined the effects of asthma on osteoporosis based on condition of asthma management.

COPD

Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life

By

Amit Akirov, MD

September 22, 2020

Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.

General Pulmonology

Lung Disease-Specific Risk Factors for Hip Fracture in Smokers

By

Amit Akirov, MD

September 22, 2020

Several lung disease-related factors may help predict the risk for hip fracture in current and former smokers.

Critical Care

Sleep Fragmentation Associated With Cognitive Impairment in ICU Survivors

By

Amit Akirov, MD

August 20, 2020

Early sleep fragmentation, estimated by actigraphy, was found to be associated with worse cognitive impairment shortly after critical illness.

Obstructive Sleep Apnea-OSA

Improvement of Sleep Apnea and Sleep Patterns May Improve Glycemic Control in Black Patients

By

Amit Akirov, MD

May 14, 2020

Sleep-disordered breathing and fragmented sleep are associated with higher levels of fasting glucose and hemoglobin A1c in black adults.

Amit Akirov, MD

All articles by Amit Akirov, MD

Increased Risk for CVST With Thrombocytopenia in J&J COVID-19 Vaccine Recipients

Safety and Efficacy of SARS-CoV-2 mRNA Vaccines in Patients With Chronic Inflammatory Diseases Demonstrated

Targeting Chronic Obstructive Pulmonary Disease Endotypes

The Need for New Biological Targets for Therapeutic Intervention in COPD

Neuropathological Changes in Autopsied Brain Tissue of Patients With COVID-19

Asthma Is Associated With Increased Risk for Osteoporosis

Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life

Lung Disease-Specific Risk Factors for Hip Fracture in Smokers

Sleep Fragmentation Associated With Cognitive Impairment in ICU Survivors

Improvement of Sleep Apnea and Sleep Patterns May Improve Glycemic Control in Black Patients

Inspire Therapy Approved for Younger Patients With Obstructive Sleep Apnea